ArticleResearch square2025
Dissemination and diffusion of research to address the opioid crisis in justice settings: a Justice Community Opioid Innovation Network (JCOIN) case study.
Article in Research square, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Background: The Justice Community Opioid Innovation Network (JCOIN), an initiative led by the National Institute on Drug Abuse since 2019, aims to improve outcomes for individuals with opioid use disorder in criminal justice settings. To increase the use of research findings in justice and health settings, the Dissemination and Stakeholder Engagement Core of JCOIN's Coordination and Translation Center crafted a unique and dynamic process to translate and disseminate research to practice organizations in parallel to clinical research studies. Methods: This study illustrates JCOIN's multi-prong diffusion and dissemination framework using both qualitative data and implementation indicators to assess reach, engagement, and effectiveness of the efforts. Investigators interviewed 44 participants and tracked engagement data from 17,737 adopters and 75 intermediary organizations that participated in 125 defined events. Participants included representatives from justice systems, health systems, community services, government, and people with lived experience (PWLE). Thematic analysis was used to identify recurring themes, while engagement metrics assessed the reach of knowledge translation products and activities. Investigators followed the Standards for Reporting Qualitative Research (SRQR) to increase the quality and transparency of this research. Results: The framework includes the identification of priority adopters of research, social system optimization, co-production with community members, and targeted knowledge translation and dissemination. The process guided the creation and distribution of 168 knowledge translation products and engaged 17,737 practitioners and stakeholders throughout a five-year period in the dissemination process. Findings illustrate the benefits of the framework in making new science more accessible to practitioners and potential adopters, as well as reducing the research and practice gap. Conclusion: This study provides insights for improving the translation and implementation of new research to priority adopters across diverse settings. The study highlights the importance of moving beyond passive approaches and emphasizes the need for purposeful dissemination and diffusion strategies to ensure findings reach and benefit intended practitioners. The findings underscore the value of an "activated diffusion" model that prioritizes building relationships with key adopters and intermediary organizations, and the co-production of knowledge translation materials to expand the reach and benefit for intended practitioners.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.